<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Richards J</submitter><funding>Research Trainees Coordinating Centre</funding><funding>National Institute for Health Research (NIHR)</funding><pagination>e031210</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6661628</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(7)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Arteriovenous fistulas (AVFs) are considered the best and safest modality for providing haemodialysis in patients with end-stage renal disease. Only 20% of UK centres achieve the recommended 80% target for achieving dialysis of the prevalent dialysis population via permanent access (as opposed to a central venous catheter). This is partly due to the relatively poor maturation rate of newly created fistulas, with as many as 50% of fistulas failing to mature.The Surveillance Of arterioveNous fistulAe using ultRasound study will examine whether a protocolised programme of Doppler ultrasound (US) surveillance can identify, early after creation, potentially correctable problems in those AVFs that subsequently fail to mature.&lt;h4>Methods and analysis&lt;/h4>This is a multicentre</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study.</pubmed_title><pmcid>PMC6661628</pmcid><funding_grant_id>ACF-2014-14-015</funding_grant_id><funding_grant_id>PDF-2016-09-065</funding_grant_id><funding_grant_id>CL-2015-14-002</funding_grant_id><funding_grant_id>CL-2018-14-008</funding_grant_id><funding_grant_id>HTA/17/27/11</funding_grant_id><funding_grant_id>17/27/11</funding_grant_id><pubmed_authors>Fitzpatrick-Creamer C</pubmed_authors><pubmed_authors>Crawford K</pubmed_authors><pubmed_authors>Hudson C</pubmed_authors><pubmed_authors>Foley C</pubmed_authors><pubmed_authors>Deary A</pubmed_authors><pubmed_authors>Ayorinde T</pubmed_authors><pubmed_authors>Parsons K</pubmed_authors><pubmed_authors>Weerasinghe T</pubmed_authors><pubmed_authors>Crane J</pubmed_authors><pubmed_authors>Carmichael SJ</pubmed_authors><pubmed_authors>Richards J</pubmed_authors><pubmed_authors>Moinuddin Z</pubmed_authors><pubmed_authors>Paul S</pubmed_authors><pubmed_authors>Daniel S</pubmed_authors><pubmed_authors>Salter T</pubmed_authors><pubmed_authors>Ghazanfar A</pubmed_authors><pubmed_authors>Gee S</pubmed_authors><pubmed_authors>Motallebzadeh R</pubmed_authors><pubmed_authors>Badhan R</pubmed_authors><pubmed_authors>Patel J</pubmed_authors><pubmed_authors>Rowe T</pubmed_authors><pubmed_authors>Hossain M</pubmed_authors><pubmed_authors>Hunter J</pubmed_authors><pubmed_authors>Lawman S</pubmed_authors><pubmed_authors>Bond K</pubmed_authors><pubmed_authors>Bagul A</pubmed_authors><pubmed_authors>Owen W</pubmed_authors><pubmed_authors>Dutta S</pubmed_authors><pubmed_authors>Kerr J</pubmed_authors><pubmed_authors>Widdup J</pubmed_authors><pubmed_authors>Trivedi K</pubmed_authors><pubmed_authors>Hyndman S</pubmed_authors><pubmed_authors>Dawson S</pubmed_authors><pubmed_authors>Hopkins V</pubmed_authors><pubmed_authors>Surendrakumar V</pubmed_authors><pubmed_authors>Bodneck C</pubmed_authors><pubmed_authors>Fleet A</pubmed_authors><pubmed_authors>Sidders A</pubmed_authors><pubmed_authors>Brand S</pubmed_authors><pubmed_authors>Bajwa A</pubmed_authors><pubmed_authors>Augustin M</pubmed_authors><pubmed_authors>SONAR trial group</pubmed_authors><pubmed_authors>Bolsworth A</pubmed_authors><pubmed_authors>Selm JV</pubmed_authors><pubmed_authors>Slater M</pubmed_authors><pubmed_authors>Eadie T</pubmed_authors><pubmed_authors>Bartlett M</pubmed_authors><pubmed_authors>Jerram A</pubmed_authors><pubmed_authors>Lai J</pubmed_authors><pubmed_authors>Burney K</pubmed_authors><pubmed_authors>Padayachee S</pubmed_authors><pubmed_authors>Cai P</pubmed_authors><pubmed_authors>Long J</pubmed_authors><pubmed_authors>Laing E</pubmed_authors><pubmed_authors>Somalanka S</pubmed_authors><pubmed_authors>Potter R</pubmed_authors><pubmed_authors>Banda J</pubmed_authors><pubmed_authors>Tambyraja A</pubmed_authors><pubmed_authors>Lena M</pubmed_authors><pubmed_authors>Summers D</pubmed_authors><pubmed_authors>Thomas H</pubmed_authors><pubmed_authors>Knight S</pubmed_authors><pubmed_authors>Hardy E</pubmed_authors><pubmed_authors>Pugh E</pubmed_authors><pubmed_authors>Edlin H</pubmed_authors><pubmed_authors>Lochiel R</pubmed_authors><pubmed_authors>Rabuya M</pubmed_authors><pubmed_authors>Beech A</pubmed_authors><pubmed_authors>Pettigrew G</pubmed_authors><pubmed_authors>Turner S</pubmed_authors><pubmed_authors>Truslove M</pubmed_authors><pubmed_authors>Lagaac R</pubmed_authors><pubmed_authors>Aslam M</pubmed_authors><pubmed_authors>Smith G</pubmed_authors><pubmed_authors>Wilson EC</pubmed_authors><pubmed_authors>Quashie-Akponeware M</pubmed_authors><pubmed_authors>Chipurovski I</pubmed_authors><pubmed_authors>Barnett N</pubmed_authors><pubmed_authors>Kosmoliaptsis V</pubmed_authors><pubmed_authors>Smith M</pubmed_authors><pubmed_authors>Ansu K</pubmed_authors><pubmed_authors>Khosla N</pubmed_authors><pubmed_authors>Lafferty K</pubmed_authors><pubmed_authors>Ngwa-Ndifor N</pubmed_authors><pubmed_authors>Bendle J</pubmed_authors><pubmed_authors>Cheal D</pubmed_authors><pubmed_authors>Eldridge P</pubmed_authors><pubmed_authors>Gibbs P</pubmed_authors><pubmed_authors>Dear K</pubmed_authors><pubmed_authors>Sivaprakasam R</pubmed_authors><pubmed_authors>Tiivas C</pubmed_authors><pubmed_authors>Morgan M</pubmed_authors><pubmed_authors>Chapman L</pubmed_authors><pubmed_authors>Allsop K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study.</name><description>&lt;h4>Introduction&lt;/h4>Arteriovenous fistulas (AVFs) are considered the best and safest modality for providing haemodialysis in patients with end-stage renal disease. Only 20% of UK centres achieve the recommended 80% target for achieving dialysis of the prevalent dialysis population via permanent access (as opposed to a central venous catheter). This is partly due to the relatively poor maturation rate of newly created fistulas, with as many as 50% of fistulas failing to mature.The Surveillance Of arterioveNous fistulAe using ultRasound study will examine whether a protocolised programme of Doppler ultrasound (US) surveillance can identify, early after creation, potentially correctable problems in those AVFs that subsequently fail to mature.&lt;h4>Methods and analysis&lt;/h4>This is a multicentre</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2026-05-07T07:03:49.791Z</modification><creation>2019-08-12T07:04:00Z</creation></dates><accession>S-EPMC6661628</accession><cross_references><pubmed>31340975</pubmed><doi>10.1136/bmjopen-2019-031210</doi></cross_references></HashMap>